Compare Kotak Healthcare Fund vs SBI Healthcare Opportunities Fund
Risk | Very High | Very High |
Rating | - | 4.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 2.34 | 1.93 |
NAV | ₹12.97 | ₹412.51 |
Fund Started | 20 Nov 2023 | 04 Jun 1999 |
Fund Size | ₹467.92 Cr | ₹3989.42 Cr |
Exit Load | 0.5% for redemption within 30 Days | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
-
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.34
1.93
NAV
₹12.97
₹412.51
Fund Started
20 Nov 2023
04 Jun 1999
Fund Size
₹467.92 Cr
₹3989.42 Cr
Exit Load
0.5% for redemption within 30 Days
Exit load of 0.50% if redeemed within 15 days
1 Year | -3.11% | -0.86% |
3 Year | - | 22.82% |
5 Year | - | 15.48% |
1 Year
-3.11%
-0.86%
3 Year
-
22.82%
5 Year
-
15.48%
Equity | 96.25% | 96.59% |
Cash | 3.75% | 3.34% |
Equity
96.25%
96.59%
Cash
3.75%
3.34%
Top 10 Holdings |
|
|
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 12.86% |
Max Healthcare Institute Ltd. | 7.26% |
JB Chemicals & Pharmaceuticals Ltd. | 6.26% |
Divi's Laboratories Ltd. | 5.46% |
Cipla Ltd. | 4.84% |
Lupin Ltd. | 4.28% |
Apollo Hospitals Enterprise Ltd. | 3.99% |
Fortis Healthcare Ltd. | 3.78% |
Acutaas Chemicals Ltd. | 3.28% |
Jubilant Pharmova Ltd. | 3.21% |
Sun Pharmaceutical Industries Ltd. | 11.64% |
Divi's Laboratories Ltd. | 7.05% |
Max Healthcare Institute Ltd. | 5.24% |
Lupin Ltd. | 4.44% |
Laurus Labs Ltd. | 3.89% |
Torrent Pharmaceuticals Ltd. | 3.86% |
Acutaas Chemicals Ltd. | 3.85% |
Cipla Ltd. | 3.79% |
Lonza Group Ag | 3.63% |
Biocon Ltd. | 3.16% |
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 20 Nov 2023 | 04 Jun 1999 |
Description
The scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
20 Nov 2023
04 Jun 1999